CWBHF

Charlotte's Web Holdings, Inc.
CAPPED RATING

Charlotte's Web Holdings, Inc. engages in farming, manufacturing, marketing, and selling hemp-derived cannabidiol (CBD) wellness products. The company's products categories include hemp extract oil tinctures, such as liquid products; gummies comprising sleep, stress, immunity, and exercise recovery products; and capsules, CBD topical creams, and lotions, as well as products for pets under the Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp brands. Its products contain naturally occurring phytocannabinoids, including CBD, cannabichromene, cannabigerol, cannabinol, terpenes, flavonoids, and other beneficial hemp compounds. The company distributes its products through retail outlets and health care practitioners, as well as online through its website. It has a collaboration between its CW Labs science division and the University at Buffalo's Center for Integrated Global Biomedical Sciences to advance hemp cannabinoid science through a research program; and scientific collaboration with McLean Hospital. The company was formerly known as Stanley Brothers Holdings Inc. and changed its name to Charlotte's Web Holdings, Inc. in July 2018. Charlotte's Web Holdings, Inc. was founded in 2013 and is headquartered in Denver, Colorado.

Charlotte's Web Holdings, Inc. (CWBHF) is rated C- (2.1/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Value (C+); its weakest is Revisions (D+). The rating has held at C- for 56 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.1 / 5.0
C-
Value
C+
Factor Score 2.6 / 5.0
Growth
C
Factor Score 2.2 / 5.0
Profitability
C
Factor Score 2.5 / 5.0
Momentum
C-
Factor Score 1.9 / 5.0
Revisions
D+
Factor Score 1.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA N/A
Rev Growth YoY 4.2%
Gross Margin 46.8%
Price Return 3M -56.6%
Price Return 12M 171.7%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales 3.1
ROE -42.1%

Historical Factor Score Progression

Held C- for 56 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-07-29 C+ (2.6) C (2.2) C (2.5) C- (1.9) D+ (1.5) C- (2.1)
2025-06-30 C+ (2.6) C (2.2) C (2.4) D+ (1.8) D+ (1.5) C- (2.1)
2025-03-31 C+ (2.7) C (2.2) C+ (2.5) C- (1.9) D+ (1.5) C (2.2)
2024-12-31 C+ (2.6) D (1.2) C (2.3) C- (1.9) D (1.5) C- (1.9)
2024-09-30 C+ (2.6) D+ (1.5) C (2.5) C- (2.0) D+ (1.5) C- (2.0)
Page 1 of 4